跳至主要内容
临床试验/NCT02376023
NCT02376023Unknown不适用

Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile: A Randomized Controlled Trial.

Pontificia Universidad Catolica de Chile4 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2016年2月22日最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
试验地点
4
主要终点
Proportion of women who received a Pap smear within 6 months from the date when the study randomization began.

研究概览

简要总结

The purpose of this study is to evaluate the implementation and effectiveness of text messages as a means for improving adherence to cervical cancer screening.

详细描述

  1. Problem Outline, Theoretical Framework and Project Justification

The problem: Cervical Cancer

Cervical cancer is a serious public health problem. Worldwide, it is the third leading cause of death of women. An estimated 270,000 women die every year due to cervical cancer, and more than 85% of these deaths take place in developing countries (1).

Chile´s national cervical cancer program was created in 1987. Since then, and with the systematic implementation of cervical cancer screening through Papanicolau (Pap) smears, cervical cancer mortality rates have dropped significantly (2,3).

In spite of all efforts, cervical cancer continues to cause the mortality of more than 500 women each year in Chile. Across the nation, only 59 percent of the population is up-to-date with their Pap, a figure that has not changed significantly in the last 10 years (2). In the Metropolitan Region, this percentage is as low as 56 percent. The distribution of cervical cancer, like that of other cancers, follows a pattern of inequality in that women of lowest socioeconomic status are those most affected (4).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Must have and use a mobile phone
  • Enrolled at one of the following clinics: CESFAM El Roble or CESFAM Juan Pablo II.
  • Must not have had a Pap test within 3 years or more from recruitment

排除标准

  • Women who have ever had the diagnosis of cervical cancer.
  • Women with a mental or physical disability that inhibits them from understanding the implications of the study or being able to reach the health clinic for an exam.
  • Women that are considering relocating within the next year.

结局指标

主要结局

Proportion of women who received a Pap smear within 6 months from the date when the study randomization began.

时间窗: 6 months after randomization of study

The information will be collected from the cancer registration and monitoring database (CITOEXPERT/REVICAN), where Pap data of the population at the national level is registered. Investigators will also review medical records from participating patients at the two health centers. The data collection will take place 6 months after initial recruitment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Javiera Martínez

Javiera Martínez MD, MPH

Pontificia Universidad Catolica de Chile

研究点 (4)

Loading locations...

相似试验

Messages For Your Health: A Cancer Screening... | 临床试验